Rating History for ZIOPHARM Oncology (ZIOP) by BMO Capital

More Stocks Rated by BMO Capital | Latest Ratings for ZIOP
Date Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
6/22/2015 N/A Downgrade Market Perform
(Outperform)		 10.00
(15.00)		 12.14
(0.87)		 -92.83% Details